NRx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ANSON FUNDS MANAGEMENT LP | 11/14/2025 | 2.03 M | $6.68 M | 26.18% | 11.29% |
| VANGUARD GROUP INC | 11/07/2025 | 534.96 K | $1.77 M | 18.31% | 2.98% |
| ADVISORSHARES INVESTMENTS LLC | 11/05/2025 | 342.14 K | $1.13 M | 29.70% | 1.91% |
| MARSHALL WACE, LLP | 11/13/2025 | 189.14 K | $624.15 K | 466.55% | 1.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 185.86 K | $613.46 K | 7.90% | 1.04% |
| UBS GROUP AG | 11/13/2025 | 152.85 K | $504.40 K | 25.69% | 0.85% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 128.18 K | $422.98 K | 100.00% | 0.71% |
| STATE STREET CORP | 11/14/2025 | 76.28 K | $251.74 K | 49.33% | 0.43% |
| JANE STREET GROUP, LLC | 11/14/2025 | 73.40 K | $242.22 K | 100.00% | 0.41% |
| BLACKROCK, INC. | 11/12/2025 | 65.41 K | $215.86 K | 1.57% | 0.36% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 52.33 K | $172.70 K | 66.39% | 0.29% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 10/30/2025 | 41.99 K | $125.98 K | 100.00% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 41.60 K | $137.28 K | 100.00% | 0.23% |
| CITADEL ADVISORS LLC | 11/14/2025 | 32.90 K | $108.57 K | 100.00% | 0.18% |
| NORTHERN TRUST CORP | 11/14/2025 | 28.60 K | $94.38 K | 0.00% | 0.16% |
| ONE WEALTH MANAGEMENT INVESTMENT & ADVISORY SERVICES, LLC | 10/29/2025 | 27.99 K | $92.37 K | 86.10% | 0.16% |
| JANE STREET GROUP, LLC | 11/14/2025 | 12.10 K | $39.93 K | 100.00% | 0.07% |
| ETHOS FINANCIAL GROUP, LLC | 10/23/2025 | 11.90 K | $39.27 K | 100.00% | 0.07% |
| MORGAN STANLEY | 11/14/2025 | 11.08 K | $36.56 K | 152.05% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 3.40 K | $11.22 K | -3.52% | 0.02% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 2.50 K | $8.25 K | -26.30% | 0.01% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 2.00 K | $6.60 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.09 K | $2.53 K | 1,111.11% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 324 | $1.07 K | -71.97% | 0.00% |
| CAROLINA WEALTH ADVISORS, LLC | 10/07/2025 | 50 | $165 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 34 | $112 | 0.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 11/14/2025 | 22 | $73 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NRx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of NRx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Anson Funds Management LP: 2.03 M
VANGUARD GROUP INC: 534,956
AdvisorShares Investments LLC: 342,136
MARSHALL WACE, LLP: 189,136
GEODE CAPITAL MANAGEMENT, LLC: 185,862
UBS Group AG: 152,848
22.06% of NRx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.19 M shares in the last 24 months. This purchase volume represents approximately $10.23 M in transactions.